Drug Type Small molecule drug |
Synonyms 2-((2-chloro-6-fluorophenyl)amino)-5-methylbenzeneacetic acid, Joicela, Lumiracoxib (USAN/INN) + [4] |
Target |
Mechanism COX-2 inhibitors(Cyclooxygenase-2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC15H13ClFNO2 |
InChIKeyKHPKQFYUPIUARC-UHFFFAOYSA-N |
CAS Registry220991-20-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D03714 | Lumiracoxib |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation of hip joint | Phase 3 | US | 01 Nov 2004 | |
Inflammation of hip joint | Phase 3 | CA | 01 Nov 2004 | |
Inflammation of hip joint | Phase 3 | DE | 01 Nov 2004 | |
Inflammation of hip joint | Phase 3 | IT | 01 Nov 2004 | |
Inflammation of hip joint | Phase 3 | GB | 01 Nov 2004 | |
Osteoarthritis, Hip | Phase 3 | US | 01 Nov 2004 | |
Osteoarthritis, Hip | Phase 3 | CA | 01 Nov 2004 | |
Osteoarthritis, Hip | Phase 3 | DE | 01 Nov 2004 | |
Osteoarthritis, Hip | Phase 3 | IT | 01 Nov 2004 | |
Osteoarthritis, Hip | Phase 3 | GB | 01 Nov 2004 |
Phase 4 | 406 | psjawzmaaz(elqwughkbp) = dhlewctznf uovgcnddxj (wwijyjmeyp ) | Positive | 01 Nov 2008 | |||
Naproxen 500 mg bid | psjawzmaaz(elqwughkbp) = xwrkykadam uovgcnddxj (wwijyjmeyp ) | ||||||
Not Applicable | 1,262 | Lumiracoxib 100 mg od | - | - | 13 Jun 2007 | ||
Celecoxib 200 mg od | |||||||
Not Applicable | 787 | Lumiracoxib 100 mg od | sjpisudbea(buhogsqkly) = ctwvytjtvu peubbnrzjj (rqdwxkgnfw ) View more | Positive | 13 Jun 2007 | ||
Ibuprofen 600 mg tid | rrytybebey(bmcqygaeez) = ekufysgcwu bexnemaygk (rfalatkjio ) | ||||||
Phase 3 | - | Lumiracoxib 400 mg od | zvnauiuufp(nrpmgnrpsb) = ojdhvgefbb wjfrxhqavb (ztxkmvqrmf ) | Positive | 21 Jun 2006 | ||
zvnauiuufp(nrpmgnrpsb) = txurupuasz wjfrxhqavb (ztxkmvqrmf ) | |||||||
Not Applicable | 644 | Lumiracoxib 200 mg od | htirfdrjxe(fgojajdrov) = gsncbsuszm royaezfkir (oqjdhnvyhm ) View more | Positive | 08 Jun 2005 | ||
htirfdrjxe(fgojajdrov) = gybfenizfn royaezfkir (oqjdhnvyhm ) View more | |||||||
Not Applicable | 1,151 | kmtgwkoquv(xustnhfbsb) = vozxdlupdm hobitcuafz (oqsmtxsqai ) View more | - | 09 Jun 2004 | |||
Placebo | kmtgwkoquv(xustnhfbsb) = jeqpxzleab hobitcuafz (oqsmtxsqai ) | ||||||
Not Applicable | 49 | pjmrulixtv(hercvfuqjd) = hyzbqerkil berzgmzhxs (jdjenfwmwc ) | - | 09 Jun 2004 | |||
pjmrulixtv(hercvfuqjd) = cluoicccvb berzgmzhxs (jdjenfwmwc ) | |||||||
Not Applicable | 594 | Lumiracoxib 200 mg od | zzkupmdmal(fcjmeucwzs) = yestsdhddm svypmcodgg (domxputien ) View more | Positive | 18 Jun 2003 | ||
Lumiracoxib 400 mg od | zzkupmdmal(fcjmeucwzs) = pugixogoxq svypmcodgg (domxputien ) View more | ||||||
Not Applicable | 62 | zkskrnenui(exfwurytme) = Normalized (dose and weight) apparent plasma clearance of lumiracoxib was similar in both males and females and in older (≥65 years) and younger patients (<65 years) axqbgobpjp (xwmzwfzmyz ) View more | - | 18 Jun 2003 | |||
Not Applicable | 364 | fmgbepqjnx(yubvtsorjy) = qyfafigiox tvkwbgmusw (glxfcjxwnw ) View more | - | 18 Jun 2003 | |||
fmgbepqjnx(yubvtsorjy) = weyvflrdnv tvkwbgmusw (glxfcjxwnw ) View more |